$HIMS is partnering with $LLY to deliver weight loss medications directly to self-pay patients. $XLV Eligible patients can access Foundayo starting at $149 a m

$HIMS is partnering with $LLY to deliver weight loss medications directly to self-pay patients. $XLV Eligible patients can access Foundayo starting at $149 a month, and Zepbound at $299. Revenue growth: Eli Lilly = 45.5% $NVO = 5.7% Hims & Hers = 28% Gross margin: Eli Lilly = 83% Novo Nordisk = 8…